IGF2 and Hypertension: The dual AT1R blockers/PPAR-γ agonist ARB could prevent apoptotic progression through the upregulation of the cardiac SIRT1/PGC-1α pro-survival pathway associated with IGF-II and p-JNK deactivation in hypertension.